Literature DB >> 22522803

Dephosphorylation of cardiac proteins in vitro - a matter of phosphatase specificity.

Cathrine Husberg1, Giulio Agnetti, Ronald J Holewinski, Geir Christensen, Jennifer E Van Eyk.   

Abstract

Protein phosphorylation is reversibly regulated by the interplay between kinases and phosphatases. Recent developments within the field of proteomics have revealed the extent of this modification in nature. To date there is still a lack of information about phosphatase specificity for different proteomes and their conditions to achieve maximum enzyme activity. This information is important per se, and in addition often requested in functional and biochemical in vitro studies, where a dephosphorylated sample is needed as a negative control to define baseline conditions. In this study, we have addressed the effectiveness of two phosphatases endogenously present in the heart (protein phosphatases 1 and 2A) and two generic phosphatases (alkaline phosphatase and lambda protein phosphatase) on three cardiac subproteomes known to be regulated by phosphorylation. We optimized the dephoshorylating conditions on a cardiac tissue fraction comprising cytosolic and myofilament proteins using 2DE and MS. The two most efficient conditions were further investigated on a mitochondrial-enriched fraction. Dephosphorylation of specific proteins depends on the phosphatase, its concentration, as well as sample preparation including buffer composition. Finally, we analyzed the efficiency of alkaline phosphatase, the phosphatase with the broadest substrate specificity, using TiO(2) peptide enrichment and 2DLC-MS/MS. Under these conditions, 95% of the detected cardiac cytoplasmic-enriched phospho-proteome was dephosphorylated. In summary, targeting dephosphorylation of the cardiac muscle subproteomes or a specific protein will drive the selection of the specific phosphatase, and each requires different conditions for optimal performance.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522803      PMCID: PMC3818568          DOI: 10.1002/pmic.201100116

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  24 in total

1.  Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye.

Authors:  Birte Schulenberg; Robert Aggeler; Joseph M Beechem; Roderick A Capaldi; Wayne F Patton
Journal:  J Biol Chem       Date:  2003-05-20       Impact factor: 5.157

Review 2.  Phosphoproteome analysis.

Authors:  Roberto Raggiaschi; Stefano Gotta; Georg C Terstappen
Journal:  Biosci Rep       Date:  2005 Feb-Apr       Impact factor: 3.840

3.  Detection of phosphorylation patterns in rat cortical neurons by combining phosphatase treatment and DIGE technology.

Authors:  Roberto Raggiaschi; Chiara Lorenzetto; Enrica Diodato; Andrea Caricasole; Stefano Gotta; Georg C Terstappen
Journal:  Proteomics       Date:  2006-02       Impact factor: 3.984

4.  Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC.

Authors:  Kris Gevaert; An Staes; Jozef Van Damme; Sara De Groot; Koen Hugelier; Hans Demol; Lennart Martens; Marc Goethals; Joël Vandekerckhove
Journal:  Proteomics       Date:  2005-09       Impact factor: 3.984

5.  Optimization of paper bridge loading for 2-DE analysis in the basic pH region: application to the mitochondrial subproteome.

Authors:  Lesley A Kane; Christina K Yung; Giulio Agnetti; Irina Neverova; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2006-11       Impact factor: 3.984

6.  Alkaline phosphatase activity and pH optima.

Authors:  M H ROSS; J O ELY; J G ARCHER
Journal:  J Biol Chem       Date:  1951-10       Impact factor: 5.157

7.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

Review 8.  Intact protein separation by chromatographic and/or electrophoretic techniques for top-down proteomics.

Authors:  Anna Laura Capriotti; Chiara Cavaliere; Patrizia Foglia; Roberto Samperi; Aldo Laganà
Journal:  J Chromatogr A       Date:  2011-06-06       Impact factor: 4.759

Review 9.  Flicking the switches: phosphorylation of serine/threonine protein phosphatases.

Authors:  D L Brautigan
Journal:  Semin Cancer Biol       Date:  1995-08       Impact factor: 15.707

10.  Isolation of the protein backbone of an arabinogalactan-protein from the styles of Nicotiana alata and characterization of a corresponding cDNA.

Authors:  H Du; R J Simpson; R L Moritz; A E Clarke; A Bacic
Journal:  Plant Cell       Date:  1994-11       Impact factor: 11.277

View more
  7 in total

1.  Phosphorylation Regulates Id2 Degradation and Mediates the Proliferation of Neural Precursor Cells.

Authors:  Jaclyn M Sullivan; Matthew C Havrda; Arminja N Kettenbach; Brenton R Paolella; Zhonghua Zhang; Scott A Gerber; Mark A Israel
Journal:  Stem Cells       Date:  2016-02-01       Impact factor: 6.277

2.  Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.

Authors:  Javier Barallobre-Barreiro; Shashi K Gupta; Anna Zoccarato; Rika Kitazume-Taneike; Marika Fava; Xiaoke Yin; Tessa Werner; Marc N Hirt; Anna Zampetaki; Alessandro Viviano; Mei Chong; Marshall Bern; Antonios Kourliouros; Nieves Domenech; Peter Willeit; Ajay M Shah; Marjan Jahangiri; Liliana Schaefer; Jens W Fischer; Renato V Iozzo; Rosa Viner; Thomas Thum; Joerg Heineke; Antoine Kichler; Kinya Otsu; Manuel Mayr
Journal:  Circulation       Date:  2016-08-24       Impact factor: 29.690

3.  LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling.

Authors:  Oscar Busnadiego; José González-Santamaría; David Lagares; Juan Guinea-Viniegra; Cathy Pichol-Thievend; Laurent Muller; Fernando Rodríguez-Pascual
Journal:  Mol Cell Biol       Date:  2013-04-09       Impact factor: 4.272

4.  Two dimensional gel phosphoproteome of peripheral blood mononuclear cells: comparison between two enrichment methods.

Authors:  Maria Teresa Rocchetti; Michela Alfarano; Leonarda Varraso; Salvatore Di Paolo; Massimo Papale; Elena Ranieri; Giuseppe Grandaliano; Loreto Gesualdo
Journal:  Proteome Sci       Date:  2014-09-09       Impact factor: 2.480

5.  MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.

Authors:  James W McNamara; Amy Li; Sean Lal; J Martijn Bos; Samantha P Harris; Jolanda van der Velden; Michael J Ackerman; Roger Cooke; Cristobal G Dos Remedios
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

Review 6.  The Histidine-Rich Calcium Binding Protein in Regulation of Cardiac Rhythmicity.

Authors:  Demetrios A Arvanitis; Elizabeth Vafiadaki; Daniel M Johnson; Evangelia G Kranias; Despina Sanoudou
Journal:  Front Physiol       Date:  2018-09-27       Impact factor: 4.566

7.  Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.

Authors:  Petr G Vikhorev; Natalia N Vikhoreva; WaiChun Yeung; Amy Li; Sean Lal; Cristobal G Dos Remedios; Cheavar A Blair; Maya Guglin; Kenneth S Campbell; Magdi H Yacoub; Pieter de Tombe; Steven B Marston
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.